How deadly is meticillin-resistant Staphylococcus aureus?

The Lancet Infectious Diseases

Volumn 14, Issue 10, 2014, Pages 905-907

  Fätkenheuer, Gerd ^a,b   Kaasch, Achim J ^b  

^a UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

^b UNIVERSITY OF COLOGNE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BETA LACTAM; VANCOMYCIN; ANTIINFECTIVE AGENT; METICILLIN;

BACTERIAL STRAIN; BACTERIAL VIRULENCE; BLOODSTREAM INFECTION; COHORT ANALYSIS; DISEASE DURATION; DRUG EFFICACY; FOLLOW UP; HUMAN; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; MORTALITY; NOTE; RISK FACTOR; TREATMENT OUTCOME; BACTEREMIA; FEMALE; ISOLATION AND PURIFICATION; MALE; PENICILLIN RESISTANCE; STAPHYLOCOCCAL INFECTIONS;

ANTI-BACTERIAL AGENTS; BACTEREMIA; FEMALE; HUMANS; MALE; METHICILLIN; METHICILLIN RESISTANCE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCAL INFECTIONS;

EID: 84908124525     PISSN: 14733099     EISSN: 14744457     Source Type: Journal    
DOI: 10.1016/S1473-3099(14)70904-1     Document Type: Note

References (12)

1. Kaasch AJ, Barlow G, Edgeworth JD, et al. Staphylococcus aureus bloodstream infection: a pooled analysis of five prospective, observational studies. J Infect 2014, 68:242-251.
2. van Hal SJ, Jensen SO, Vaska VL, Espedido BA, Paterson DL, Gosbell IB Predictors of mortality in Staphylococcus aureus Bacteremia. Clin Microbiol Rev 2012, 25:362-386.
3. Cameron DR, Howden BP, Peleg AY The interface between antibiotic resistance and virulence in Staphylococcus aureus and its impact upon clinical outcomes. Clin Infect Dis 2011, 53:576-582.
4. Yaw LK, Robinson JO, Ho KM A comparison of long-term outcomes after meticillin-resistant and meticillin-sensitive Staphylococcus aureus bacteraemia: an observational cohort study. Lancet Infect Dis 2014, published online Sept 1. http://dx.doi.org/10.1016/S1473-3099(14)70876-X.
5. Ammerlaan H, Seifert H, Harbarth S, et al. Adequacy of antimicrobial treatment and outcome of Staphylococcus aureus bacteremia in 9 western European countries. Clin Infect Dis 2009, 49:997-1005.
6. Paul M, Kariv G, Goldberg E, Raskin M, et al. Importance of appropriate empirical antibiotic therapy for methicillin-resistant Staphylococcus aureus bacteraemia. J Antimicrob Chemother 2010, 65:2658-2665.
7. Kaasch AJ, Rieg S, Kuetscher J, et al. Delay in the administration of appropriate antimicrobial therapy in Staphylococcus aureus bloodstream infection: a prospective multicenter hospital-based cohort study. Infection 2013, 41:979-985.
8. Wenzel RP, Edmond MB Infection control: the case for horizontal rather than vertical interventional programs. Int J Infect Dis 2010, 14(suppl 4):S3-S5.
9. Bode LG, Kluytmans JA, Wertheim HF, et al. Preventing surgical-site infections in nasal carriers of Staphylococcus aureus. N Engl J Med 2010, 362:9-17.
10. Huang SS, Septimus E, Kleinman K, et al. Targeted versus universal decolonization to prevent ICU infection. N Engl J Med 2013, 368:2255-2265.
11. Rieg S, Peyerl-Hoffmann G, de With K, et al. Mortality of S aureus bacteremia and infectious diseases specialist consultation-a study of 521 patients in Germany. J Infect 2009, 59:232-239.
12. López-Cortés LE, Del Toro MD, Gálvez-Acebal J, et al. Impact of an evidence-based bundle intervention in the quality-of-care management and outcome of Staphylococcus aureus bacteremia. Clin Infect Dis 2013, 57:1225-1233.